AIHA
AIHA
AIHA
ABSTRACT
Coombs positive hemolytic anemia is exceedingly rare in tuberculosis. We herein report a patient with tuberculosis associated with Coombs positive hemolytic anemia that was responded to antituberculosis therapy. She was
admitted to the hospital because of recent-onset fatigue, weakness, nonproductive cough, pallor and scleral jaundice. Coombs positive hemolytic anemia and pulmoner tuberculosis was diagnosed. Following antituberculosis therapy, laboratory and clinical finding related to autoimmune hemolytic anemia disappeared.
Key Words: Tuberculosis, Autoimmune hemolytic anemia, Coombs positivity.
Turk J Haematol 2002;19(4): 477-480
Received: 29.04.2002
Acceppted: 13.08.2002
INTRODUCTION
Tuberculosis is a multi-systemic specific infection,
which can lead protean manifestations in any organsystem. Therefore, the clinical presentation of the disease is quite diverse. Hematological finding in tuberculosis is not uncommon and usually due to non-immunological mechanisms. Normochrom normocythic anemia is the most frequent hematological finding at presentation and during the long clinical course of tuberculosis. Anemia is usually due to bone marrow granuloma, nutritional insufficiency, malabsorption and im-
477
and body temperature 39.5C orally. In the examination of the respiratory system, there were fine rales heard in the left apical zone during inspiration and expiration together with a harsh bronchial noise. There was
a systolic cardiac murmur of grade I-II heard all over
the precordium. The laboratory findings on admission
revealed a WBC 6600/mm3 (75% neutrophils, 13%
lymphocytes, 11% monocytes and 0.5% eosinophiles),
hemoglobin 4.6 g/dL, MCV 98.7 and MCH of 22.7 fL,
platelet count 175.000/mm3 and reticulocyte 19.7%.
Direct and indirect Coombs test was positive without
any transfusion. Erythrocyte morphology was polychromacytic together with macrocytosis, spherocytosis,
anisopoikilocytosis and 6% normoblasts. Bone marrow
examination disclosed significant erythroid hyperplasia and hypercellularity. Biochemical tests on admission were: Total bilirubin 4 g/dL, direct bilirubin 1.9
g/dL, AST 295 IU/L, ALT 81 IU/L, LDH 1902 U/L,
ferritin 7685 ng/dL and haptoglobin 31 mg/dL. In the
chest X-ray there was bilateral reticulonodular infiltration in the upper zones and in the high resolution computerized tomography bilateral apical reticulonodular
infiltration and a cavitary lesion 2 cm in diameter seen
in the right upper lobe posterior segment (Figures 1,2).
Tests for ANA, anti-DNA, HIV and blood cultures were all negative. In the bronchoalveolar lavage obtained
from the right upper pole there were acid-fast bacilli
and Mycobacterium tuberculosis was cultivated in the
Lwenstein-Jensen agar.
The drug regimen including INH 300 mg PO, rifampicine 450 mg PO, pyrazinamide 1500 mg PO and
streptomycine 750 mg IM was initiated in April 2001.
After one week time fever was subsided. Since the liver enzymes were elevated (ALT 540 IU/L and AST
560 IU/L), all of the drugs except streptomycin were
holded and ethambutol 1500 mg PO was added to the
treatment schema. When the enzymes (ALT and
AST) were 39 IU/L and 100 IU/L respectively INH,
pyrazinamide and rifampicine were added to the drug
regimen with 5 days of intervals. There were no increments in the enzymes following the reinitiation of the
treatment. The control laboratory tests of the patient
are depicted in Table 1.
No blood or blood product was given to the patient
and the clinical symptoms were gradually improved.
Patient is discharged because of her will to continue the
treatment at home in June 2001. The sputum examina-
478
Figure 1. Anteroposterior X-ray of the chest on admission showing bilateral reticulonodular infiltration in
upper zones.
Table 1. Essential laboratory findings and follow-up of the patient with tuberculosis and hemolytic anemia
Parameters
On admission
4.6
12.2
Reticulocyte (%)
19.7
0.98
LDH (IU/L)
1902
270
4.6/1.9
0.32/0.05
88
20
37
18
31 (N above 50)
80
Hemoglobin (g/dL)
Bilirubin-total/direct (mg/dL)
AST (IU/L)
ALT (IU/L)
Haptoglobin (mg/dL)
REFERENCES
1.
2.
3.
4.
5.
6.
479
7.
8.
9.
Ouz A, Kanra T, Gkalp A, et al. Acute hemolytic anemia caused by irregular rifampicin therapy. Turk J Pediatr 1989;31:83-8.
Letona JM, Barbolla L, Frieyro E, et al. Immune hemolytic anemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561-71.
Mueller-Eckhardt C, Kretschmer V, Coburg KH. Allergic, immunohemolytic anemia due to para-aminosalicylic acid (PAS). Immunohematologic studies of three cases. Dtsch Med Wochenschr 1972;97:234-8.
480